Sol-Gel Technologies (SLGL) Cash & Equivalents Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - | -43.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -43.39% |
| Sep 30, 2025 | -50.04% |
| Jun 30, 2025 | -11.50% |
| Mar 31, 2025 | 50.67% |
| Dec 31, 2024 | 159.40% |
| Sep 30, 2024 | -5.06% |
| Jun 30, 2024 | -26.05% |
| Mar 31, 2024 | 64.71% |
| Dec 31, 2023 | -39.64% |
| Sep 30, 2023 | 66.27% |
| Jun 30, 2023 | 170.91% |
| Mar 31, 2023 | -67.98% |
| Dec 31, 2022 | -38.02% |
| Sep 30, 2022 | -80.39% |
| Jun 30, 2022 | -48.31% |
| Mar 31, 2022 | 68.07% |
| Dec 31, 2021 | 182.01% |
| Sep 30, 2021 | 621.64% |
| Jun 30, 2021 | 104.85% |
| Mar 31, 2021 | 475.08% |
| Dec 31, 2020 | -24.33% |
| Sep 30, 2020 | -21.37% |
| Jun 30, 2020 | -62.16% |
| Mar 31, 2020 | -73.10% |
| Dec 31, 2019 | 76.75% |
| Sep 30, 2019 | -42.41% |
| Jun 30, 2019 | -21.12% |
| Mar 31, 2019 | -89.76% |
| Dec 31, 2018 | 5.99% |
| Dec 31, 2017 | -28.24% |